classification of Acinetobacter baumannii clinical isolates to international clones

Similar documents
Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt

Longitudinal Analysis of the Temporal Evolution of Acinetobacter baumannii Strains in Ohio, USA, by Using Rapid Automated Typing Methods

Epidemiological characterization and distribution of carbapenemresistant Acinetobacter baumannii clinical isolates in Italy

ORIGINAL ARTICLE /j x

Heteroresistance to Meropenem in Carbapenem-Susceptible Acinetobacter baumannii

Received 19 November 2009/Returned for modification 14 January 2010/Accepted 12 February 2010

Clonal Diversity of Nosocomial Epidemic Acinetobacter baumannii Strains Isolated in Spain

Acinetobacter Outbreaks: Experience from a Neurosurgery Critical Care Unit. Jumoke Sule Consultant Microbiologist 19 May 2010

Department of Clinical Microbiology, Nottingham University Hospitals NHS Trust, Queen s Medical Centre, Nottingham, UK

ESCMID elibrary. Symposium: Acinetobacter Infections from East to West. Molecular Epidemiology Worldwide

Pneumonia caused by extensive drugresistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality

Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period ( )

Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France.

AbaR7, a Genomic Resistance Island Found in Multidrug-resistant Acinetobacter baumannii Isolates in Daejeon, Korea

Acinetobacter sp. isolates from emergency departments in two hospitals of South Korea

Molecular Characterization of Mycoplasma agalactiae. Reveals the Presence of an Endemic Clone in Spain

Molecular Epidemiology and Insights into the Genomes of. Acinetobacter calcoaceticus - Acinetobacter baumannii complex

Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities

Multi-drug resistant Acinetobacter (MDRA) Surveillance and Control. Alison Holmes

Sequential Outbreaks of Infections by Distinct Acinetobacter baumannii Strains in a Public Teaching Hospital in Houston, Texas

Molecular characterization of carbapenemase genes in Acinetobacter baumannii in China

Analysis of drug-resistant gene detection of blaoxa-like genes from Acinetobacter baumannii

Available online at journal homepage:

Drd. OBADĂ MIHAI DORU. PhD THESIS ABSTRACT

Acinetobacter Resistance in Turkish Tertiary Care Hospitals. Zeliha KOCAK TUFAN, MD, Assoc. Prof.

High prevalence and clonal dissemination of OXA-72-producing Acinetobacter baumannii in a Chinese hospital: a cross sectional study

Testing for antimicrobial activity against multi-resistant Acinetobacter baumannii. For. Forbo Flooring B.V. Final Report. Work Carried Out By

Annals of Clinical Microbiology and Antimicrobials. Open Access RESEARCH

Molecular epidemiological study of clinical Acinetobacter baumannii isolates: phenotype switching of antibiotic resistance

β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa March 2018

DRUG-RESISTANT ACINETOBACTER BAUMANNII A GROWING SUPERBUG POPULATION. Cara Wilder Ph.D. Technical Writer March 13 th 2014

Originally published as:

Dissemination of Class 1, 2 and 3 Integrons among Different Multidrug Resistant Isolates of Acinetobacter baumannii in Tehran Hospitals, Iran

Molecular Epidemiology and Antimicrobial Resistance Determinants of Multidrug-Resistant Acinetobacter baumannii in Five Proximal Hospitals in Taiwan

Presence of extended spectrum β-lactamase producing Escherichia coli in

Warner et al. BMC Infectious Diseases (2016) 16:194 DOI /s y

Original Article. Suthan Srisangkaew, M.D. Malai Vorachit, D.Sc.

RESEARCH NOTE. Molecular epidemiology of carbapenemresistant Acinetobacter baumannii in New Caledonia

Decrease of vancomycin resistance in Enterococcus faecium from bloodstream infections in

Molecular identification of tigecycline- and colistinresistant carbapenemase-producing Acinetobacter baumannii from a Greek hospital from 2011 to 2013

Yu jun Li 1, Chu zhi Pan 2, Zi wen Zhao 1*, Zhu xiang Zhao 1, Hui ling Chen 3 and Wei bo Lu 1

Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy)

Microbiology Unit, Hua Hin Hospital, Prachuap Khiri Khan, Thailand

Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU

Neisseria meningitidis ANTIMICROBIAL RESISTANCE:CURRENT SITUATION IN LATIN AMERICA AND ITS CLINICAL RELEVANCE

Development of a Multilocus Sequence Typing Scheme for Characterization of Clinical Isolates of Acinetobacter baumannii

DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA

Clinical Center of Microbiology Research, Ilam University of Medical Sciences, Ilam, Iran b

Overnight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii in. Kuwait

Antimicrobial Cycling. Donald E Low University of Toronto

What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh

Endemic and Epidemic Acinetobacter Species in a University Hospital: an 8-Year Survey

Pedro Martínez and Salim Mattar* ABSTRACT

Georgios Meletis, Efstathios Oustas, Christina Botziori, Eleni Kakasi, Asimoula Koteli

Characterization of the Multidrug-Resistant Acinetobacter

Int J Clin Exp Med 2016;9(6): /ISSN: /IJCEM

Absence of LA-MRSA CC398 as nasal colonizer of pigs raised

USING DNA TO EXPLORE LIZARD PHYLOGENY

The molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in the major countries of East Asia

Molecular epidemiology and antibiotic susceptibility pattern of Acinetobacter baumannii isolated from children in a Turkish university hospital

ETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens

Original Article Clinical Microbiology INTRODUCTION

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

Received 28 June 2006/Returned for modification 20 July 2006/Accepted 19 September 2006

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Summary of the latest data on antibiotic consumption in the European Union

Staphylococcus aureus Programme 2007 (SAP 2007) Hospital Survey MRSA Epidemiology and Typing Report

Acinetobacter baumannii producing OXA-23 detected in the Czech Republic

Mechanisms and Pathways of AMR in the environment

Isolation, molecular identification and antimicrobial susceptibility of Acinetobacter baumannii isolated from Baghdad hospitals

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium

Research in rabbit science. University of Bari

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Antimicrobial resistance (EARS-Net)

Microbiological Surveillance of Methicillin Resistant Staphylococcus aureus (MRSA) in Belgian Hospitals in 2003

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City

Impact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital

Maria Giannouli 1, Luísa CS Antunes 2, Veronica Marchetti 1, Maria Triassi 1, Paolo Visca 2* and Raffaele Zarrilli 1*

Fighting MDR Pathogens in the ICU

MDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta

BLA-NDM-1 IN CLINICAL ISOLATES OF Acinetobacter baumannii FROM NORTH INDIA

Mechanism of antibiotic resistance

Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania

Dr Nata Menabde Executive Director World Health Organization Office at the United Nations Global action plan on antimicrobial resistance

Acinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia.

Campylobacter infections in EU/EEA and related AMR

Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran

Genome sequence of OXA 23 producing Acinetobacter baumannii IHIT7853, a carbapenem resistant strain from a cat belonging to international clone IC1

EARS Net Report, Quarter

Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017

Identification of Multidrug-Resistant Genes in Acinetobacter baumannii in Sulaimani City-Kurdistan Regional Government of Iraq

Co-transfer of bla NDM-5 and mcr-1 by an IncX3 X4 hybrid plasmid in Escherichia coli 4

Antimicrobial stewardship in companion animals: Welcome to a whole new era

Epidemiological Characteristics and Drug Resistance Analysis of Multidrug-Resistant Acinetobacter baumannii in a China Hospital at a Certain Time

Transcription:

JCM Accepts, published online ahead of print on 12 March 2014 J. Clin. Microbiol. doi:10.1128/jcm.03565-13 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 3 Single locus sequence-based typing of blaoxa-51-like gene for rapid classification of Acinetobacter baumannii clinical isolates to international clones 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Spyros Pournaras, a Vasiliki Gogou, b Maria Giannouli, c Evangelia Dimitroulia, a Konstantina Dafopoulou, d Athanasios Tsakris, a Raffaele Zarrilli c Department of Microbiology, Medical School, University of Athens, Athens, Greece; a Department of Microbiology b and Department of Hygiene and Epidemiology, d Faculty of Medicine, University of Thessaly, Larissa, Greece; Department of Public Health, University of Naples Federico II, Naples, Italy c Running title: Prompt bla OXA-51-like sequence typing of A. baumannii Address correspondence to Spyros Pournaras, spournaras@med.uoa.gr

18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 Abstract The single-locus bla OXA-51-like sequence-based typing (SBT) was evaluated for its ability to determine correctly sequence types (STs) in Acinetobacter baumannii clinical isolates, in comparison with the Pasteur s multilocus sequence typing (MLST) reference method and the 3-locus sequence typing (3-LST). The comparative study was performed in 585 multidrug-resistant (MDR) A. baumannii clinical isolates recovered from 21 hospitals located throughout Greece, Italy, Lebanon and Turkey. Using the bla OXA-51-like SBT, all 585 isolates were typed and assigned correctly to 13 distinct STs, determined by the MLST. The isolates belonged to nine clonal complexes (CC), which are predominant worldwide among nosocomial MDR A. baumannii isolates and to one singleton ST. The most common clone was CC2 (comprising ST2 and ST45), which included 278 isolates that all harbored the bla OXA-66 allele, followed by CC1 (ST1 and ST20) with 155 isolates that carried bla OXA-69. The remaining lineages that were identified were CC3 (carrying the bla OXA-71 allele), CC6 (bla OXA-94), CC10 (bla OXA-128), CC15 (ST15 and ST84, bla OXA- 51), CC25 (bla OXA-64), CC54 (bla OXA-365), CC83 (bla OXA-86) and ST78 (bla OXA-90). The 3- LST did not classify CC6, CC10, CC54 and CC83 isolates, being not yet characterized in its data base. The low-cost and convenient bla OXA-51-like SBT, compared with 3-LST and MLST, discriminated all epidemic and sporadic lineages of our collection and could be effectively applied to type rapidly A. baumannii strains. 39 Keywords: MLST; sequence types; 3-LST; bla OXA-51-like SBT

40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 Introduction Outbreaks due to multidrug-resistant Acinetobacter baumannii clinical strains are increasingly documented worldwide (1). Currently, A. baumannii strains causing hospital outbreaks are usually belonging to a limited number of clonal lineages, among which those applying to the international clones I and II are prevailing (1-3). This development increasingly necessitates monitoring the epidemic evolution of A. baumannii strains, by grouping them to specific clonal lineages. For this purpose, several genotyping methods exist, such as the 3-locus sequence-based typing (3- LST) (3), ribotyping (4), infrequent-restriction site analysis (5), rep-pcr (6), amplified fragment length polymorphism (7), electrospray ionization mass spectrometry (8), pulsed-field gel electrophoresis (PFGE) (9) and multilocus sequence-typing (MLST) (10, 11). Among the methods most commonly used for tracking the worldwide clonal dissemination of A. baumannii, as reference, gold standard method is considered the MLST, of which two schemes exist, the PubMLST (11) and the Pasteur MLST (10). Both schemes are based on sequences of seven housekeeping genes and are used for global, but also for local, epidemiological studies. Concerning MLST, it still remains to be answered whether several loci are required to obtain robust results and if the selection of housekeeping genes is sufficiently reliable to reveal population structures. For instance, the PubMLST genes gyrb and gpi present recombination, resulting in failure to type some isolates (12). Another method that has been widely applied and produced accurate results for the classification of worldwide clones is the 3-LST scheme (3). It involves amplification and sequencing of the genes ompa, csue and bla OXA-51-like that are under selective pressure and assigns A. baumannii strains to six different sequence groups (SGs), 1 to 6,

65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 corresponding to international clonal lineages identified by other methods (2, 3, 13, 14). Based on 3-LST, two multiplex PCRs were also designed to selectively amplify the ompa, csue and bla OXA-51-like alleles that correspond to SGs 1, 2, 3 and 6 (3, 14) without being followed by sequencing, thus serving as a convenient preliminary method to study local epidemiology. The increasing need for molecular surveillance of multidrug-resistant A. baumannii in the current era of financial restrictions prompts investigation for reliable typing approaches requiring lower time, labor and costs. One of the simplest approaches for the identification (17) and typing (12) of A. baumannii involves amplification and sequencing of the bla OXA-51-like gene, which is unique to A. baumannii, although was occasionally detected in Acinetobacter nosocomialis and Acinetobacter genomic species close to 13TU (18). The potential of the specific bla OXA-51-like identification to correctly assign A. baumannii isolates to international clones as single-locus based typing (SBT) has been scarcely evaluated previously on international collections, in comparison only with PubMLST (12) and rep-pcr (19). In the present study, the performance of this simple, low-cost and rapid SBT was evaluated in a large international collection of A. baumannii strains in parallel with the widely used Institute Pasteur s MLST and 3-LST schemes. Materials and Methods Bacterial collection. A collection including 585 A. baumannii clinical isolates recovered between 2000 and 2010 from four different countries (Italy, Greece, Turkey, Lebanon), representing most common worldwide lineages, was tested. The isolates included in this collection were recovered during outbreaks that occurred in at least 20 unrelated hospitals in the four countries from 1999 to 2009.

90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 Representative isolates of this collection were characterized molecularly previously (13-16). Although not all of the study isolates were selected because of a multidrug resistance (MDR) phenotype, almost all of them actually exhibited MDR and > 80% were carbapenem-resistant. Identification of isolates as A. baumannii was initially performed by PCR and sequencing of bla OXA-51-like (17) and was confirmed with subsequent assignment of isolates by MLST to clonal lineages specific for A. baumannii. SBT, 3-LST and MLST. All isolates were tested using the 3-LST protocol developed by the UK HPA (3), involving initially two multiplex PCR identifying only SGs 1, 2, 3 and 6, and subsequently sequencing, confirming the grouping and discriminating SGs 1, 2, 3, 4, 5, 6 and 7 available at the Health Protection Agency website (http://www.hpa-bioinformatics.org.uk/ab/home.php). The sequencing of solely bla OXA51-like using primers encompassing the total gene (forward primer: 5 - ATGAACATTAAAGCACTCTTAC-3, reverse primer: 5 - CTATAAAATACCTAATTGTTCT-3 ; 825-bp amplicon) was applied as a separate approach for typing the isolates. These primers include the start and stop codons and few OXA-51-like variants that differ from the common alleles at the 5 and 3 proximities could be misidentified. Nevertheless, the primers were able to amplify bla OXA-51-like alleles of all 585 strains included in our collection. Furthermore, all isolates were tested by the MLST scheme developed by the Pasteur institute (10), which served as gold standard method, against which the other approaches were evaluated. This scheme involves PCR amplification and sequencing of seven housekeeping genes (fusa, glta, pyrg, reca, cpn60, rpob, and rplb). E burst. To determine the Clonal Complexes (CCs) where isolates belonged, e- BURST analysis was performed using the eburst software program

115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 (http://eburst.mlst.net/). Phylogeny trees. Neighbor-joining phylogenetic trees based on bla OXA-51-like genes and concatenated alleles of the seven housekeeping genes of Pasteur s MLST scheme were constructed using the phylogeny.fr platform (20) available at: http://www.phylogeny.fr/. Results ST types of the studied isolates using the Pasteur s MLST scheme. Table 1 represents the origin, the typing results and the classification of the isolates using the three different typing schemes. Overall, by using the reference Pasteur s MLST scheme, 13 ST types (ST1, ST2, ST3, ST15, ST25, ST45, ST54, ST78, ST82, ST83, ST84, ST85, ST86) were identified among the 585 A. baumannii isolates of the study. SBT results. In comparison with the MLST, SBT identified correctly isolates belonging to all major lineages. In particular, the two major international clonal lineages corresponding to CC1 and CC2 each carried a single bla OXA-51-like variant. All isolates carrying identical bla OXA-69 belonged to CC1, which included the founder ST of CC1 (ST1) and its single locus variant (SLV) ST20. CC2 isolates, consisting in our collection of ST2 and the SLV ST45, in all cases carried identical bla OXA-66. Isolates belonging to CC3, CC10, CC15, CC25, CC54, ST78, CC83, ST85, ST86 and ST94 all carried a unique bla OXA-51-like variant (Table 1). Finally, isolates of CC32 and CC79, although not available in the present collection, could be effectively typed by SBT, as was shown using data obtained from the GenBank; CC32 isolates carry bla OXA-100 (GenBank accession number AM231720) and CC79 isolates carry bla OXA-65

139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 (accession numbers AY50908 and JQ412185) (Table 1). These data clearly showed that CC1 and CC2 predominated in this international collection. The relatively limited number of OXA-51-like alleles that were identified among the study isolates, prompted a GenBank search of all publicly available whole-genome sequences of A. baumannii. The results of this search are shown in the Supplementary Table 1. In particular, of the 104 strains available that belonged to ST2, 98 harbored OXA-66 or the single aminoacid variant OXA-82; OXA-66 allele had identical nucleotide sequence in all strains and OXA-82 had identical sequence in all but two strains that harbored alleles differing by 1-nt. Also, 2 and 1 strains assigned to ST2 harbored the single aminoacid variants OXA-109 and OXA-254, respectively and 3 strains harbored OXA-113 that differed in six aminoacid residues from OXA-66, thus suggesting that a limited variability of bla OXA-51-like gene existed into international clonal linage 2. Despite this variability, SBT was able to correctly type and assign to international clonal lineage 2 all ST2 strains available in GenBank. Furthermore, all 28 ST1 strains harbored identical OXA-69, 6/8 ST3 strains harbored OXA-71 and 2/8 harbored an allele (OXA-312) with 1-nt difference, 1/2 CC10 strain harbored OXA-68 with the other one to harbor an allele (OXA-128) with 1-nt difference, 7/7 CC25 strains harbored identical OXA-64, 3/3 CC32 strains harbored OXA-100 and 3/3 CC79 strains harbored identical OXA-65. 3-LST results. The 3-LST scheme, although overall provided data relatively to three genes under selective pressure, failed to classify isolates belonging to CC10, CC54, CC83, ST85, CC32 and CC79, as alleles corresponding to these lineages are not yet assigned in its data base. Twelve isolates, identified as ST54, ST82, ST83 and ST85 are considered to belong to micro-epidemic lineages, not assigned to any SG. As far

163 164 as the simple and rapid 3-LST multiplex PCR, it discriminated only SG1 (CC2), SG2 (CC1), SG3 (CC3) and SG6 (ST78). 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 Discussion Several methods have been applied during the last two decades to identify the clonal lineages of A. baumannii isolates. Among them, the most common ones have been 3-LST (3) and MLST (10, 11). These methods are appropriately discriminatory but can be considered either time-consuming/labor-intensive or costly. Amplification and sequencing of bla OXA-51-like gene has been used successfully for A. baumannii identification and within 3-LST scheme, respectively. It has also been observed during 3-LST analysis (3) that bla OXA-51-like variants are conserved within most SGs and often correlate well with the MLST types, thus deserving investigation for the potential of bla OXA-51-like SBT to be utilized as an independent typing scheme. Up to now, this possibility was tested in parallel only with the PubMLST scheme (12), against which the bla OXA-51-like SBT was shown to identify accurately isolates belonging to the three major epidemic lineages. In another study, the bla OXA-51-like SBT compared with rep-pcr identified the international clonal lineages I to III and worldwide clonal lineages 4 to 8 (19). In the current report, the performance of bla OXA-51-like SBT was compared with the Pasteur s MLST scheme, which does not exhibit recombination in its target loci in contrast with the PubMLST, and also with 3-LST, including both the initial multiplex PCR and the sequencing analysis. The total bla OXA-51-like gene was sequenced, as the cost is the same and the nucleotide yield is bigger, enabling the identification of novel bla OXA-51-like variants, such as the bla OXA-365 allele corresponding to ST54. This comparison was applied on a large, diverse collection of 585 A. baumannii strains from several countries, including

188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 most common lineages. This collection was also tested by PFGE but these results were not included in the current presentation due to that PFGE is not suitable for international population studies. In the tested collection, bla OXA-51-like SBT identified successfully the common lineages CC1, CC2, CC3, CC10, CC15 and CC25. It was also shown in the publicly available databases that the remaining rather common clones CC32 and CC79, each contain a specific bla OXA-51-like allele (bla OXA-100 and bla OXA-65, respectively) and can be efficiently identified by the bla OXA-51-like SBT. A single bla OXA-51-like allele was found to correspond to two different STs (bla OXA-69 to ST1 and ST20; bla OXA-66 to ST2 and ST45), which however were included in the same CC, not affecting prompt identification of the respective international lineage. In all cases, the same bla OXA-51- like allele was detected in strains belonging to the same CC and no case was observed where different bla OXA-51-like alleles were detected in the same ST. In contrast, the application of bla OXA-51-like SBT in comparison with the PubMLST (12) resulted to both the detection of the same bla OXA-51-like allele in unrelated STs (bla OXA- 51 in CC4 and ST20) and of distinct alleles in a single lineage (bla OXA-69 and bla OXA-112 in International clone I; bla OXA-82 and bla OXA-83 in ST22; bla OXA-107 and bla OXA-110 in ST49; bla OXA-51 and bla OXA-68 in ST20). The correlation of bla OXA-51-like with PubMLST was better when alleles exhibiting recombination (gpi and gyrb) were excluded from the analysis (12). In this study, testing 585 multidrug resistant clinical isolates, only 13 STs were identified, while at least 450 STs are currently distinguishable by the Pasteur s MLST. However, it is well known that the high diversity of the general population of A. baumannii at the strain level especially involves susceptible strains (10). Also, although this large collection includes also epidemiologically related isolates, these isolates came

213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 from numerous unrelated hospitals in four different countries, indicating the circulation of limited clones in the hospital epidemiological niche and supporting the observed bottleneck effect for MDR A. baumannii (10). Furthermore, the present analysis that detected identical alleles in multiple A. baumannii isolates from each lineage, underlines the intra-strain stability of typing characteristics using the bla OXA-51-like SBT method. The reliability of the bla OXA-51-like SBT method is further validated by the analysis of A. baumannii whole genome sequences (WGS) available in GenBank. Despite a slight variability of bla OXA-51-like gene found in A. baumannii strains belonging to international clone 2 and also within the predominant international clones 1 and 3 (supplementary Table 1), this SBT is able to correctly type and assign to the major international clonal lineages A. baumannii WGS available in GenBank. These data indicate that the vast majority of the predominant lineages of A. baumannii could be effectively identified by this SBT and clearly support our view for the clinical applicability of the bla OXA-51-like SBT as a simple first-line typing approach. As far as 3-LST, although this scheme analyzes three loci and provides more comprehensive data from an evolutionary point of view, than the bla OXA-51-like SBT, it has not yet been applied in collections large enough to identify all common lineages. Its data base currently includes only SG2 (CC1 according to Pasteur s scheme), SG1 (CC2), SG3 (CC3), SG4 (CC25), SG5 (CC15), SG6 (ST78) and SG7, which were all identified in our collection. In that respect, the bla OXA-51-like SBT, compared with 3- LST, identified more ST types defined by MLST. However, it is evident that a future application of 3-LST in larger collections representing all lineages might further discriminate strains. We should note herein for 3-LST that two unrelated strains were previously shown to carry bla OXA-51-like that corresponds to CC1, but a csue allele that was characteristic of CC2 (21). However, both of these strains actually belonged to CC1

238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 by MLST and it was concluded that they had acquired the csue gene from other A. baumannii strains. In fact one of these strains, A388, carried OXA-92 (12), which differs from OXA-69 by only one nucleotide (22), indicating that it would be correctly grouped by OXA-51-like SBT as CC1. It is thus indicated that we should treat with caution results including the csue allele, such as the 3-LST and that OXA-51-like alleles are possibly more conserved and may correlate better with MLST than the 3-LST scheme. Finally, as could be anticipated, the simple multiplex PCR of the 3-LST scheme when applied as an independent method identified fewer SGs than the other typing approaches tested. Concluding remarks. Overall, the bla OXA-51-like SBT compared with the Pasteur s MSLT and 3-LST was shown to identify accurately isolates belonging to all major A. baumannii lineages that were available in our collection. It can be assumed that this SBT, being evidently easier, faster and cheaper than MLST, could be applied efficiently for the provisional molecular typing of A. baumannii. References 1. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582. 2. Zarrilli R, Pournaras S, Giannouli M, Tsakris A. 2013. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int. J. Antimicrob. Agents 41:11-19. 3. Turton JF, Gabriel SN, Valderrey S, Kaufmann ME, Pitt TL. 2007. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin. Microbiol. Infect. 13:807 815. 4. Brisse S, Milatovic D, Fluit AC, Kusters K, Toelstra A, Verhoef J, Schmitz FJ.

263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 2000. Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping. J. Clin. Microbiol. 38:3636-3645. 5. Yoo JH, Choi JH, Shin WS, Huh DH, Cho YK, Kim KM, Kim MY, Kang MW. 1999. Application of infrequent-restriction-site PCR to clinical isolates of Acinetobacter baumannii and Serratia marcescens. J. Clin. Microbiol. 37:3108-3112. 6. Huys G, Cnockaert M, Vaneechoutte M, Woodford N, Nemec A, Dijkshoorn L, Swings J. 2005. Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals. Res. Microbiol. 156:348-355. 7. Spence RP, van der Reijden TJ, Dijkshoorn L, Towner KJ. 2004. Comparison of Acinetobacter baumannii isolates from United Kingdom hospitals with predominant Northern European genotypes by amplified-fragment length polymorphism analysis. J. Clin. Microbiol. 42:832-834. 8. Ecker JA, Massire C, Hall TA, Ranken R, Pennella TT, Agasino Ivy C, Blyn LB, Hofstadler SA, Endy TP, Scott PT, Lindler L, Hamilton T, Gaddy C, Snow K, Pe M, Fishbain J, Craft D, Deye G, Riddell S, Milstrey E, Petruccelli B, Brisse S, Harpin V, Schink A, Ecker DJ, Sampath R, Eshoo MW. 2006. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J. Clin. Microbiol. 44:2921-2932. 9. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn LJ. 2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 43:4328-4335. 10. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. 2010. The population

288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5: e10034. 11. Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodríguez- Valera F. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43:4382-4390. 12. Hamouda A, Evans BA, Towner KJ, Amyes SG. 2010. Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla OXA-51-like genes. J. Clin. Microbiol. 48:2476-2483. 13. Giannouli M, Tomasone F, Agodi A, Vahaboglu H, Daoud Z, Triassi M, Tsakris A, Zarrilli R. 2009. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals. J. Antimicrob. Chemother. 63:828 830. 14. Giannouli M, Cuccurullo S, Crivaro V, Di Popolo A, Bernardo M, Tomasone F, Amato G, Brisse S, Triassi M, Utili R, Zarrilli R. 2010. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J Clin. Microbiol. 48:1223 1230. 15. Di Popolo A, Giannouli M, Triassi M, Brisse S, Zarrilli R. 2011. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clin. Microbiol. Infect. 17:197-201. 16. Gogou V, Pournaras S, Giannouli M., Voulgari E., Piperaki E.-T, Zarrilli R, Tsakris A. 2011. Evolution of multidrug-resistant Acinetobacter baumannii clonal

313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 lineages: a 10 years study in Greece (2000-2009). J. Antimicrob. Chemother. 66:2767-2772. 17. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. 2006. Identification of Acinetobacter baumannii by detection of the bla OXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44:2974-2976. 18. Lee YT, Kuo SC, Chiang MC, Yang SP, Chen CP, Chen TL, Fung CP. 2012. Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a bla OXA-51-like gene that is intrinsic to Acinetobacter baumannii. Antimicrob. Agents Chemother. 56:1124-1127. 19. Zander E, Nemec A, Seifert H, Higgins PG. 2012. Association between β- lactamase-encoding bla (OXA-51) variants and DiversiLab rep-pcr-based typing of Acinetobacter baumannii isolates. J. Clin. Microbiol. 50:1900-1904. 20. Post V, Hamidian M, Hall RM. 2012. Antibiotic-resistant Acinetobacter baumannii variants belonging to global clone 1. J. Antimicrob. Chemother. 67:1039-1040. 21. Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard JF, Guindon S, Lefort V, Lescot M, Claverie JM, Gascuel O. 2008. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 36 (Web Server Issue):W465-469. 22. Tsakris A, Ikonomidis A, Spanakis N, Pournaras S, Bethimouti K. 2007. Identification of a novel bla (OXA-51) variant, bla (OXA-92), from a clinical isolate of Acinetobacter baumannii. Clin. Microbiol. Infect. 13:348-349.

336 337 338 339 340 341 342 343 Legend to Figure 1. Neighbor-joining phylogenetic trees based on bla OXA-51like genes (panel A) and concatenated alleles of the seven housekeeping genes of Pasteur s MLST scheme (panel B). The dendrograms show the amounts of genetic change based on multiple alignments and are generated using phylogeny.fr software (19). The bar at the bottom of each figure shows the amount of genetic change corresponding to the length of each branch. Downloaded from http://jcm.asm.org/ on December 24, 2018 by guest

A B

Table 1. Characteristics of the 585 study isolates. Index Strain* Country bla OXA-51-like allele (No of isolates) Pasteur s MLST 3LST group CC cpn60 fusa glta pyrg reca rpib rpob ST (No of isolates) AB3990 Italy bla OXA-66 (278) CC2 2 2 2 2 2 2 2 ST2 (265) AB3 Greece 2 2 6 2 2 2 2 ST45 (13) AB700 Italy 1 1 1 1 5 1 1 ST1 (124) bla OXA-69 (155) CC1 AB2979 Italy 3 1 1 1 5 1 1 ST20 (31) AB3237 Lebanon bla OXA-71 (4) CC3 3 3 2 2 3 1 3 ST3 (4) 3 AB3890 Greece bla OXA-64 (65) CC25 3 3 2 4 7 2 4 ST25 (65) 4 AB3909 Italy bla OXA-90 (62) singleton 25 3 6 2 28 1 29 ST78 (62) 6 AB6 Greece bla OXA-94 (3) CC6 5 2 4 1 3 3 4 ST85 (3) NA AB17 Greece bla OXA-365 ** (3) CC54 12 3 18 2 17 4 5 ST54 (3) NA AB3868 Turkey 6 6 8 2 3 5 4 ST15 (6) bla OXA-51 (9) CC15 AB3871 Turkey 6 6 8 2 3 5 30 ST84 (3) AB2977 Italy bla OXA-128 (4) CC10 28 3 2 1 4 4 4 ST82 (4) NA AB3866 Turkey bla OXA-86 (2) CC83 26 4 2 2 9 1 4 ST83 (2) NA OIFC032 Germany bla OXA-100 *** CC32 1 1 2 2 3 4 4 ST32 NA AB_TG27343 USA bla OXA-65 **** CC79 26 2 2 2 29 4 5 ST79 NA * Index strains for dendrogram analyses ** bla OXA-365, GenBank accession number KF885217 *** bla OXA-100, GenBank accession number AM231720 **** bla OXA-65, GenBank accession numbers AY50908 and JQ412185 (Sahl et al. PlosONE, 2013;8,e54287) Abbreviations: CC, clonal complex; ST, sequence type; 3LST, trilocus sequence-based typing; NA, not available. 1 2 5